Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-21
1999-01-19
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514302, 514332, 514333, 514335, 514336, 514338, 514339, 514341, 514343, 514357, 546 2, 546115, 546255, 546256, 546261, 546266, 546268, 546270, 546271, 546273, 546278, 546281, 546283, 546284, 546286, 546329, A61K 3144, A61K 31435, C07D21170, C07D491056
Patent
active
058614079
ABSTRACT:
A class of substituted 1,2,3,6-tetrahydropyridine derivatives are disclosed that are ligands for dopamine receptor subtypes within the body. These compounds are therefore useful in the treatment and/or prevention of disorders of the dopamine system, in particular schizophrenia or depression.
REFERENCES:
patent: 3965102 (1976-06-01), Hauck et al.
patent: 4169200 (1979-09-01), Hauck et al.
patent: 5576336 (1996-11-01), Baker et al.
Curtis Neil Roy
Kulagowski Janusz Jozef
Leeson Paul David
Mawer Ian Michael
Ridgill Mark Peter
Durette Philippe L.
Merck Sharp & Dohme Ltd.
Spivack Phyllis G.
Winokur Melvin
LandOfFree
Tetrahydropyridine derivatives as dopamine receptor subtype liga does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydropyridine derivatives as dopamine receptor subtype liga, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydropyridine derivatives as dopamine receptor subtype liga will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246880